QWM
SNOA icon

Quaker Wealth Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Quaker Wealth Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$7 – 1581
2025
Q1 		$7 Buy
+3
New +$8 ﹤0.01% 913

Other funds holding SNOA

MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

Quaker Wealth Management's SNOA Position: Q2 2026 in Review

Quaker Wealth Management held its Sonoma Pharmaceuticals (SNOA) position steady in Q2 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Quaker Wealth Management first reported a position in SNOA in Q2 2025 and has held it in 5 quarters since. The position peaked at $12 in Q3 2025. 2 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

  • Quaker Wealth Management held 3 shares of Sonoma Pharmaceuticals worth $4 as of Q2 2026.
  • Quaker Wealth Management left its Sonoma Pharmaceuticals share count unchanged in Q2 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #968 holding.
  • Quaker Wealth Management first reported a position in Sonoma Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Sonoma Pharmaceuticals position peaked at $12 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.